Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Zillow Group Inc Class A — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.93 (market cap $1.74B), while Zillow Group Inc Class A trades at $29.43 (market cap $6.59B). The key difference: Zillow Group Inc Class A is far larger — about 3.8× Nuvation Bio Inc. Class A Common Stock's market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Zillow Group Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Zillow Group Inc Class A for 87 Days on average.
| NUVB | ZG | |
|---|---|---|
Market Cap | $1.74B | $6.59B |
Volume | 9,289,619 | 1,361,381 |
Sector | Health | Media |
52-Week High | $9.54 | $74.58 |
52-Week Low | $3.41 | $27.70 |
Typical Hold Time | 0 Days | 87 Days |
Enterprise Value | $1.33B | $6.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zillow Group (ZG) trades at $30.00, up 7.26% over 24 hours, but remains in a technical downtrend with bearish moving average signals. The company reported a return to profitability in 2025 with net income of $23 million, though its P/E ratio of 130 is high. Recent earnings have shown volatility, with a miss in Q4 2025 but beats in subsequent quarters. Analyst sentiment is mixed, with a consensus 'Hold' rating and a price target of $48.87, suggesting significant potential upside from the current price.
The outlook for ZG hinges on execution in a challenging housing market. Opportunities include strong revenue growth and market leadership, but risks involve high valuation, affordability headwinds, and intense competition. The stock appears undervalued relative to analyst targets, but investors must weigh the premium valuation against macroeconomic pressures on the housing sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
